Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-7444

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-7444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\ra\desktop\1.jpg (5a5eca60 Figure 01)

This text seems to detail blood pressure readings (in mmHg) at different time points for individuals taking different medications. The medications mentioned include Valsartan-HCTZ, Valsartan, Hydrochlorothiazide, and Placebo. The baseline systolic blood pressure (SBP) values are listed, and it appears that the aim was to maintain SBP below 140 mmHg. The specific dosages of the medications are also indicated.*

FDA Label Image

C:\users\ra\desktop\2.jpg (5a5eca60 Figure 02)

This is a list showing blood pressure measurements and medication information in a clinical trial setting. The study involves Valsartan-HCTZ (a combination medication of Valsartan and Hydrochlorothiazide) and a placebo. The baseline for diastolic blood pressure (DBP) is 105 mmHg, and the goal is to achieve a DBP of less than 90 mmHg. The Valsartan-HCTZ dosage is 320/25 mg, where 320 mg is Valsartan and 25 mg is Hydrochlorothiazide.*

FDA Label Image

C:\users\ra\desktop\3.jpg (5a5eca60 Figure 03)

This text appears to be a table showing blood pressure measurements in mmHg for different groups taking Valsartan-HCTZ 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, or placebo. The table includes baseline SBP readings and SBP values at different increments.*

FDA Label Image

C:\users\ra\desktop\4.jpg (5a5eca60 Figure 04)

This text provides information about blood pressure measurements in a study comparing Valsartan-HCTZ 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. It mentions a baseline diastolic blood pressure of less than 80 mmHg.*

FDA Label Image

C:\users\ra\desktop\5.jpg (5a5eca60 Figure 05)

FDA Label Image

C:\users\ra\desktop\6.jpg (5a5eca60 Figure 06)

FDA Label Image

Label Image (Lbl500907444)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.